Home/Southern African Journal of HIV Medicine/Article Record
Peer-Reviewed Article September 15, 2020

Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Southern African Journal of HIV Medicine
Publisher: AOSIS • South Africa • 1608-9693 • 2078-6751
DOI: https://doi.org/10.4102/sajhivmed.v21i1.1115

Abstract

What is new in the 2020 guidelines update? Key updatesÿ A recommendation for dolutegravir (DTG)-based therapies as the preferred first-line antiretroviral therapy (ART) option (section 11).ÿ Updated guidelines for second-and third-line ART regimens (section 13).ÿ New recommendations on the management of patients on DTG-based therapies who have an elevated viral load (section 12).ÿ A lowering of the threshold for virological failure from 1000 copies/mL to 50 copies/mL (section 8).ÿ A recommendation against routine cluster of differentiation 4 (CD4 + ) monitoring in patients who are clinically well once the CD4 + count is > 200 cells/μL (section 9).ÿ Updated recommendations for isoniazid preventive therapy (IPT) in human immunodeficiency virus (HIV)-positive patients (section 27).ÿ A recommendation for the use of low-dose prednisone as prophylaxis for paradoxical tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) in TB/HIV co-infected patients commencing ART within 1 month of TB therapy (section 26). Preamble Key principlesAlthough many antiretroviral therapy (ART) guidelines are available internationally, the current guidelines have been written to address issues relevant to southern Africa.A major spur for the current guidelines is the introduction of dolutegravir (DTG) into first-and second-line ART regimens.Dolutegravir-based ART regimens hold much promise, although the transition inevitably challenges existing paradigms and generates additional complexities.These guidelines aim to address many of these and to update the text in general to reflect the latest evidence.As with previous iterations, these guidelines take affordability into account, as countries in the region vary according to their low-and middle-income status.Hence, only the treatment and diagnostic options that are available in southern Africa are included.In addition, these guidelines recognise the need to bridge the gap in treatment recommendations between public and private sector programmes, considering that many patients transition between the two sectors for treatment.The format of this iteration of the guidelines has been modified to highlight each section's key points and common pitfalls.It will also be released over time as multiple stand-alone modules, designed with an emphasis on readability, ease of access and user-friendliness. Goals of antiretroviral therapyThe goals of ART are to:• provide maximal and durable suppression of viral load (VL) • restore and/or preserve immune function • reduce human immunodeficiency virus (HIV)-related infectious and non-infectious morbidity • prolong life expectancy and improve quality of life • prevent onward transmission of HIV • minimise adverse effects of the treatment

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

78
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.